Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals

Revista Portuguesa de Cardiologia

Volumn 31, Issue 4, 2012, Pages 329-336

  Alfonso, Fernando ^a   Timmis, Adam ^a   Pinto, Fausto J ^a   Ambrosio, Giuseppe ^a   Ector, Hugo ^a   Kulakowski, Piotr ^a   Vardas, Panos ^a  

^a NONE

Author keywords

Conflict of interest; Disclosure; Editorial ethics; Journals

Indexed keywords

ADULT; CASE REPORT; CONFLICT OF INTEREST; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL SOCIETY; POLICY; QUESTIONNAIRE; REVIEW; SCIENTIFIC LITERATURE;

EID: 84862733559     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2011.12.014     Document Type: Short Survey

References (49)

1. International Committee of Medical Journals Editors. Uniform Requirements for Manuscript Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (Updated October 2008). http://www.icmje.org/
2. Council of Science Editors. CSE's White Paper on Promoting Integrity in Scientific Journal Publications. Editorial policy committee (2005-2006). http://www.CouncilScienceEditors.org
3. World Association of Medical Editors. WAME recommendations on Publication Ethics and Policies for Medical Journals. http://www.wame.org/resources/ethics- resources
4. Committee On Publication Ethics. COPE. Code of Conduct and Best Practice Guidelines for Journal Editors. http://publicationethics.org/resources/ guidelines
5. Alfonso F, Bermejo J, Segovia J. New recommendations of the international committee of medical journal editors. Shifting focus: from uniformity in technical requirements to bioethical considerations. Rev Esp Cardiol. 2004;57:592-3.
6. Blum JA, Freeman K, Dart RC, et al. Requirements and definitions in conflict of interest policies of medical journals. JAMA. 2009;302:2230-4.
7. Cooper RJ, Gupta M, Wilkes MS, et al. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med. 2006;21:1248-52.
8. Bekelman JE, MPhil YL, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454-65.
9. DeAngelis CD, Fontanarosa PB. Resolving unreported conflicts of interest. JAMA. 2009;302:198-9.
10. Studdert DM, Mello MM, Phil M, et al. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry. Self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891-900.
11. Drazen JM, Van der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med. 2009;361:1896-7.
12. Drazen JM, De Leeuw PW, Laine C, et al. Toward more uniform conflict disclosures - the updated ICMJE conflict of interest reporting form. N Engl J Med. 2010;363:188-9.
13. Alfonso F, Ambrosio G, Pinto FJ, et al. European National Society cardiovascular journals, background, rationale and mission statement of the 'Editors' Club'. Rev Esp Cardiol. 2008;61:644-50.
14. Alfonso F, Ambrosio G, Pinto FJ, et al. Editors' Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the 'Editors' Network'. Eur Heart J. 2010;31:26-8.
15. Mills P, Timmis A, Huber K, et al. The role of European national journals in education. Heart. 2009;95:e3.
16. Alfonso F. The Editors' Network of the European Society of Cardiology. Eur Heart J. 2011;32:919-21.
17. Schwartz RS, Curfman GD, Morrissey S, et al. Full disclosure and the funding of biomedical research. N Engl J Med. 2008;358:1850-1.
18. Simone J. More interest in conflicts of interest. Lancet Oncol. 2009;10:836-7.
19. Conti RC. Conflict of interest. Clin Cardiol. 2009;32:666-7.
20. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest. Financial aspects of research and role of sponsors in funded studies. JAMA. 2005;294:110-1.
21. Alpert JS. Doctors and the drug industry: how can we handle potential conflicts of interest? Am J Med. 2005;118:99-100.
22. Alpert JS. Doctors and the drug-industry: further thoughts for dealing with potential conflicts of interest? Am J Med. 2008;121:253-5.
23. Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009;84:771-5.
24. Bove A. Relations with industry: thoughts on claims of a broken system. J Am Coll Cardiol. 2009;54:177-9.
25. Bodenheimer T. The uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342:1539-44.
26. Goldacre B. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes BMJ. 2009;339:b4949.
27. Davidoff F, De Angelis CD, Drazen JM, et al. International Committee of Medical Journal Editors. Sponsorship, authorship and accountability. Lancet. 2001;358:854-6.
28. Johns MM, Barners M, Florencio PS. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. JAMA. 2003;289:741-6.
29. Alfonso F, Segovia J, Heras M, et al. Publication of clinical trials in scientific journals: editorial issues. Rev Esp Cardiol. 2006;59:1206-14.
30. Patsopoulos NA, Analatos AA, Ioannidis JP. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006;332:1061-4.
31. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167-70.
32. Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med. 2004;117:842-5.
33. Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals. Mayo Clin Proc. 2009;84:811-21.
34. Krzyanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003;290:495-501.
35. Chan AW, Krleza-Jeric K, Schmid I, et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004;171:735-40.
36. Alfonso F, Bermejo J, Segovia J. Duplicate or redundant publication: can we afford it? Rev Esp Cardiol. 2005;58:601-4.
37. Hirsch L. Randomized clinical trials: what gets published, and when? CMAJ. 2004;170:481-3.
38. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002;325:249.
39. Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for profit and not-for-profit organizations: 2000-2005. JAMA. 2006;295:2270-4.
40. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editors practices and authors disclosures. Sci Eng Ethics. 2001;7:205-18.
41. Ancker JS, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics. 2007;13:147-57.
42. Weinfurt KP, Seils DM, Tzeng JP, et al. Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents. PLoS ONE. 2008;3:e2128.
43. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med. 2005;2:e138.
44. The Editors. Publishing commentary by authors with potential conflicts of interest: when, why and how. Ann Intern Med. 2004;141:73-4.
45. Vorobiof G. Do conflict of interest really matter or does no one read the fine print anyway? J Am Coll Cardiol. 2008;51:1911.
46. Tanne JH. US Senate committee investigates conflicts of interest in industry funded medical education. BMJ. 2009;339:b3139.
47. Rothman KJ. Conflict of interest. The new McCarthyism in science. JAMA. 1993;269:2782-4.
48. Avanzas P, Bayes-Genis A, Perez de Isla L, et al. Ethical considerations in the publication of scientific articles. Rev Esp Cardiol. 2011;64:427-9.
49. Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology. Eur Heart J. 2012;33:666-74.